These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32912853)

  • 1. The cost-effectiveness of hypertension management in low-income and middle-income countries: a review.
    Kostova D; Spencer G; Moran AE; Cobb LK; Husain MJ; Datta BK; Matsushita K; Nugent R
    BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32912853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of health systems strengthening interventions in improving maternal and child health in low- and middle-income countries: a systematic review.
    Zeng W; Li G; Ahn H; Nguyen HTH; Shepard DS; Nair D
    Health Policy Plan; 2018 Mar; 33(2):283-297. PubMed ID: 29253136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
    Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
    PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of surgery in low- and middle-income countries: a systematic review.
    Grimes CE; Henry JA; Maraka J; Mkandawire NC; Cotton M
    World J Surg; 2014 Jan; 38(1):252-63. PubMed ID: 24101020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.
    Leech AA; Kim DD; Cohen JT; Neumann PJ
    Value Health; 2018 Jul; 21(7):759-761. PubMed ID: 30005746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.
    Erfani P; Bhangdia K; Stauber C; Mugunga JC; Pace LE; Fadelu T
    Oncologist; 2021 Aug; 26(8):e1406-e1417. PubMed ID: 34050590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
    Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
    Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.
    Ochalek J; Lomas J
    Clin Ther; 2020 Jan; 42(1):44-59.e2. PubMed ID: 31955967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review.
    Fung A; Horton S; Zabih V; Denburg A; Gupta S
    BMJ Glob Health; 2019; 4(5):e001825. PubMed ID: 31749998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for the prevention of cardiovascular diseases: a protocol for a systematic review of economic evaluations in low-income and middle-income countries.
    Aminde LN; Veerman L
    BMJ Open; 2016 Dec; 6(12):e013668. PubMed ID: 28003298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review.
    Malhotra A; Thompson RR; Kagoya F; Masiye F; Mbewe P; Mosepele M; Phiri J; Sambo J; Barker A; Cameron DB; Davila-Roman VG; Effah W; Hutchinson B; Laxy M; Newsome B; Watkins D; Sohn H; Dowdy DW
    Implement Sci; 2022 Nov; 17(1):76. PubMed ID: 36384807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of injury and trauma care in low- and middle-income countries: a review of economic evidence.
    Wesson HK; Boikhutso N; Bachani AM; Hofman KJ; Hyder AA
    Health Policy Plan; 2014 Sep; 29(6):795-808. PubMed ID: 24097794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Evaluations of Child Nutrition Interventions in Low- and Middle-Income Countries: Systematic Review and Quality Appraisal.
    Baek Y; Ademi Z; Paudel S; Fisher J; Tran T; Romero L; Owen A
    Adv Nutr; 2022 Feb; 13(1):282-317. PubMed ID: 34510178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling hypertension treatment in 24 low-income and middle-income countries: economic evaluation of treatment decisions at three blood pressure cut-points.
    Hutchinson B; Walter A; Campbell N; Whelton PK; Varghese C; Husain MJ; Nugent R; Kostova D; Honeycutt A
    BMJ Open; 2024 Apr; 14(4):e071036. PubMed ID: 38626959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness and budget impact of the community-based management of hypertension in Nepal study (COBIN): a retrospective analysis.
    Krishnan A; Finkelstein EA; Kallestrup P; Karki A; Olsen MH; Neupane D
    Lancet Glob Health; 2019 Oct; 7(10):e1367-e1374. PubMed ID: 31537367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for estimating economic benefits of surgical interventions in low-income and middle-income countries: a scoping review.
    Hilla A; Reese V; Nonvignon J; Dolan CB
    BMJ Open; 2020 Dec; 10(12):e039644. PubMed ID: 33268411
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.